Skip to main content

Find Clinical Trials

Home
Conditions
AK104(PD-1/CTLA-4 Bispecial Antibody)

Clinical trial condition

AK104(PD-1/CTLA-4 Bispecial Antibody)

Explore clinical trials studying AK104(PD-1/CTLA-4 Bispecial Antibody). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

AK104(PD-1/CTLA-4 Bispecial Antibody) trial results

Not Yet Recruiting

Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer

NCT06542549

Conditions: AK104(PD-1/CTLA-4 Bispecial Antibody), Advanced Ovarian Cancer, Chemotherapy, +2 more
Locations: Not specified

View Trial Details